Midatech Limited
Oxford, GB· latest recorded location
Midatech Limited is named on 22 US grants and 23 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 22
- Published applications
- 23
- Inventors
- 40
- Granted in 2026 so far
- 0
- Most recent grant
- 1 Feb 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 1 | 1 |
| 2009 | 0 | 3 |
| 2010 | 0 | 0 |
| 2011 | 1 | 0 |
| 2012 | 0 | 4 |
| 2013 | 3 | 1 |
| 2014 | 3 | 5 |
| 2015 | 5 | 3 |
| 2016 | 2 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 2 | 1 |
| 2021 | 2 | 1 |
| 2022 | 1 | 0 |
By publication year.
Technology areas
Share of 45 documents
- A61KMedicines and medical preparations45
- A61PTherapeutic uses of medicines44
- B82YSpecific uses or applications of nanostructures26
- Y10TTechnical subjects covered by former us classification14
- Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests11
- Y02ATechnologies for adaptation to climate change8
- G01NInvestigating or analysing materials by determining their chemical or physical properties7
- A61JContainers specially adapted for medical or pharmaceutical purposes6
- A61MDevices for delivering substances into the body4
- C07KPeptides4
Recent patents
- Cyclodextrin-panobinostat adduct1 Feb 2022US 11,235,068 B2
- Nanoparticle-based liver-targeting therapy23 Nov 2021US 11,179,344 B2
- Nanoparticle-based liver-targeting therapy and imaging23 Nov 2021US 11,179,474 B1
- Cyclodextrin-panobinostat adduct28 Jul 2020US 10,722,597 B2
- Nanoparticles and their use in cancer therapy23 Jun 2020US 10,688,125 B2
- Nanoparticle-Based Liver-Targeting Therapy14 Jan 2021US 2021/0007997 A1
- Cyclodextrin-Panobinostat Adduct26 Nov 2020US 2020/0368367 A1
- Cyclodextrin-panobinostat adduct23 May 2019US 2019/0151468 A1
- Nanoparticles and their use in cancer therapy30 Nov 2017US 2017/0340665 A1
- Nanoparticle-insulin and insulin analogue compositions6 Aug 2015US 2015/0216942 A1
Most cited
By later US patents
- Nanoparticles for providing immune responses against infectious agents33US 8,895,023 B22014
- Nanoparticles8US 7,364,919 B22008
- Peptide-carrying nanoparticles4US 8,568,781 B22013
- Nanoparticles and their use in cancer therapy2US 10,688,125 B22020
- Nanoparticles for providing immune responses against infectious agents2US 8,425,915 B22013